These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1222 related articles for article (PubMed ID: 16302732)
21. Induction of cytolytic activity by anti-T3 monoclonal antibody. Activation of alloimmune memory cells and natural killer cells from normal and immunodeficient individuals. Suthanthiran M; Williams PS; Solomon SD; Rubin AL; Stenzel KH J Clin Invest; 1984 Dec; 74(6):2263-71. PubMed ID: 6392343 [TBL] [Abstract][Full Text] [Related]
22. Use of anti-HLA antibodies to mask major histocompatibility complex gene products on tumor cells can enhance susceptibility of these cells to lysis by natural killer cells. Lobo PI; Spencer CE J Clin Invest; 1989 Jan; 83(1):278-87. PubMed ID: 2463268 [TBL] [Abstract][Full Text] [Related]
23. Cell surface molecules involved in NK recognition by cloned cytotoxic T lymphocytes. Brooks CG; Holscher M J Immunol; 1987 Mar; 138(5):1331-7. PubMed ID: 3543127 [TBL] [Abstract][Full Text] [Related]
24. Suppression of natural killer cell activity by rabbit antibody to human beta 2-microglobulin (beta 2m) is an Fc-mediated phenomenon and is not beta 2m specific. Jones RA; Richards SJ; Patel D; Scott CS Immunology; 1991 Jul; 73(3):342-7. PubMed ID: 1831793 [TBL] [Abstract][Full Text] [Related]
25. Evidence for the role of class I and class II HLA antigens in the lytic function of a cloned line of human natural killer cells. Kornbluth J; Spear B; Raab SS; Wilson DB J Immunol; 1985 Feb; 134(2):728-35. PubMed ID: 3965573 [TBL] [Abstract][Full Text] [Related]
26. Relationship between antibody-dependent cell-mediated cytotoxicity due to anti-HTLV-1 and negative signal of major histocompatibility complex class I antigens on adult T-cell leukemia cell lines. Komatsu F; Tamiya H Oncol Res; 1998; 10(2):59-67. PubMed ID: 9666513 [TBL] [Abstract][Full Text] [Related]
27. MHC class I antigens, immune surveillance, and tumor immune escape. Garcia-Lora A; Algarra I; Garrido F J Cell Physiol; 2003 Jun; 195(3):346-55. PubMed ID: 12704644 [TBL] [Abstract][Full Text] [Related]
28. Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes. Garnett CT; Palena C; Chakraborty M; Tsang KY; Schlom J; Hodge JW Cancer Res; 2004 Nov; 64(21):7985-94. PubMed ID: 15520206 [TBL] [Abstract][Full Text] [Related]
29. Human monocytes expressing a CEA-specific chimeric CD64 receptor specifically target CEA-expressing tumour cells in vitro and in vivo. Biglari A; Southgate TD; Fairbairn LJ; Gilham DE Gene Ther; 2006 Apr; 13(7):602-10. PubMed ID: 16397508 [TBL] [Abstract][Full Text] [Related]
30. Carcinoembryonic antigen as a target for specific antitumor immunotherapy of head and neck cancer. Kass ES; Greiner JW; Kantor JA; Tsang KY; Guadagni F; Chen Z; Clark B; De Pascalis R; Schlom J; Van Waes C Cancer Res; 2002 Sep; 62(17):5049-57. PubMed ID: 12208760 [TBL] [Abstract][Full Text] [Related]
31. Streptococcal preparation OK-432 promotes the capacity of dendritic cells (DCs) to prime carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocyte responses induced with genetically modified DCs that express CEA. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Katsuda M; Miyazawa M; Iida T; Yamaue H Int J Oncol; 2008 Feb; 32(2):459-66. PubMed ID: 18202769 [TBL] [Abstract][Full Text] [Related]
32. A human NK and K cell subset shares with cytotoxic T cells expression of the antigen recognized by antibody OKT8. Perussia B; Fanning V; Trinchieri G J Immunol; 1983 Jul; 131(1):223-31. PubMed ID: 6408172 [TBL] [Abstract][Full Text] [Related]
33. A novel CEA vaccine stimulates T cell proliferation, gammaIFN secretion and CEA specific CTL responses. Parsons T; Spendlove I; Nirula R; Writer M; Carter G; Carr F; Durrant LG Vaccine; 2004 Sep; 22(25-26):3487-94. PubMed ID: 15308376 [TBL] [Abstract][Full Text] [Related]
34. The use of hybrid hybridomas to target human cytotoxic T lymphocytes. Lanzavecchia A; Scheidegger D Eur J Immunol; 1987 Jan; 17(1):105-11. PubMed ID: 3102250 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review). Hoskin DW; Mader JS; Furlong SJ; Conrad DM; Blay J Int J Oncol; 2008 Mar; 32(3):527-35. PubMed ID: 18292929 [TBL] [Abstract][Full Text] [Related]
36. Human leukocyte antigen class I expression on squamous cell carcinoma cells regulates natural killer cell activity. Lutz CT; Kurago ZB Cancer Res; 1999 Nov; 59(22):5793-9. PubMed ID: 10582701 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of NK binding to K562 cells induced by MAb saturation of adhesion molecules on target membrane. Papa S; Gregorini A; Pascucci E; Bartolucci M; Rocchi MB; Valentini M Eur J Histochem; 1994; 38 Suppl 1():83-90. PubMed ID: 8547716 [TBL] [Abstract][Full Text] [Related]
38. Neuroendocrine regulation and tumor immunity. Toni R; Mirandola P; Gobbi G; Vitale M Eur J Histochem; 2007; 51 Suppl 1():133-8. PubMed ID: 17703604 [TBL] [Abstract][Full Text] [Related]
39. Enhanced cell-mediated tumor killing in patients immunized with human monoclonal antiidiotypic antibody 105AD7. Durrant LG; Buckley TJ; Denton GW; Hardcastle JD; Sewell HF; Robins RA Cancer Res; 1994 Sep; 54(18):4837-40. PubMed ID: 8069847 [TBL] [Abstract][Full Text] [Related]